Retatrutide is a novel triple-receptor agonist peptide currently being studied for its effects on metabolic function, body composition, and energy regulation. Unlike traditional single-target compounds, Retatrutide is designed to activate GLP-1, GIP, and glucagon receptors, making it a unique area of interest in obesity and metabolic research.

Researchers are investigating Retatrutide for its potential to:

Support reductions in body weight and body fat

Influence appetite regulation and satiety signaling

Enhance energy expenditure and metabolic activity

Improve glucose metabolism and insulin sensitivity

Support favorable changes in body composition

Investigate effects on liver fat and metabolic health

Due to its multi-receptor mechanism, Retatrutide has become a significant focus in research exploring weight management, energy balance, and metabolic optimization.

Research Use Only. Not for human consumption. This product is intended exclusively for laboratory and scientific research purposes.